Healthmax Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.48 M
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 89.25%
- Ebitda 89.65%
- Net Worth -0.71%
- Total Assets -0.26%
About Healthmax Pharma
Healthmax Pharma Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2001 and has a history of 23 years and three months. Its registered office is in New Delhi, Delhi.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.48 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Kumar and Namita Anil serve as directors at the Company.
Company Details
-
LocationNew Delhi, Delhi
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231DL2001PTC112851
-
Company No.
112851
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Healthmax Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kumar
|
Director | 17-Oct-2001 | Current |
|
Namita Anil
|
Director | 17-Oct-2001 | Current |
Financial Performance of Healthmax Pharma.
Healthmax Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 89.25% increase in profit. The company's net worth dipped by a decrease of 0.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healthmax Pharma?
In 2023, Healthmax Pharma had a promoter holding of 20.83% and a public holding of 79.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ankita Agritech Industries Private LimitedAnil Kumar and Namita Anil are mutual person
-
Ankita Overseas India Private Limited
Anil Kumar and Namita Anil are mutual person
-
Swan Laxmi Private Limited
Anil Kumar is a mutual person
-
Ankita Global India Private Limited
Anil Kumar and Namita Anil are mutual person
-
Maheshwar Laxmi Memorial Foundation
Anil Kumar and Namita Anil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healthmax Pharma?
Unlock and access historical data on people associated with Healthmax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healthmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healthmax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.